Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.469ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.469ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.469EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.469EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.469ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.469ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.220EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.220EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.220ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.220ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.220EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.220EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.220ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.220ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.58EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.58EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.58ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.58ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.58EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.58EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.58ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.58ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.258.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.6ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.258.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.258.6EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.258.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.258.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.438EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.438EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.438ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.438ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.438EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.438EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.438ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.438ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.257EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.257EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.257ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.257ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.257EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.257EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.257ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.257ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.17EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.17ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.17ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used